Impacting the Opioid Crisis: Prevention, Education, and Practice for Non-Prescribing Providers

Thursday, February 16, 2023, 12:00 AM - Saturday, January 31, 2026, 11:45 PM


AMA PRA Category 1 Credits™ (16.00 hours), ABA MOCA Part 2 (16.00 hours), Controlled Substance Prescribing (8.00 hours), Non-Physician Attendance (16.00 hours), Pain and Symptom Management (8.00 hours)

This course will empower non-prescribing providers to directly impact the ongoing opioid crisis in the United States through increased knowledge and tools that will transform practice and policies. The course will inform you about the opioid epidemic and provide information and research about evidence-based strategies that are focused on prevention, intervention, education, or policy. This open learning course is designed primarily for non-prescribing healthcare, behavioral health, dental and social services professionals, as well as graduate-level students in these fields. Other individuals may also benefit from this course such as educators and physicians. As a learner, you have the ability to select any or all of the modules and topics that interest you. You can complete the course in a linear or non-linear structure according to your preferred viewing order. This course is taught by experts in the field of opioid prevention, intervention, treatment, and policy. Through lectures, panels and interviews, knowledge checks and quizzes, and additional readings and activities, you can explore topics that are most relevant to your work or practice. After completing this activity, participants will be able to educate their patients on the safe use of opioids and the prevention of misuse, detect risk factors for opioid misuse and abuse, and refer patients to additional evidence-based resources. The course was developed by three University of Michigan programs, including the Institute for Healthcare Policy and Innovation (IHPI), the Opioid Prescribing Engagement Network (OPEN) and the CDC-funded University of Michigan Injury Prevention Center. The course consists of 6 lessons or modules of varying length, for a total commitment of about 16 hours. Course modules include: Epidemiology of the Opioid Crisis Understanding of Pain Prevention of Misuse and Abuse Working with Patients and the Public Addiction Treatment and Recovery Public Policy

 

For questions regarding this activity please contact any of the following coordinators:

• Emma Steppe
• Nichole Burnside
• Emilee Coulter-Thompson 
• Emily McKanna 
• Elizabeth Seese   
• Karen Farris
• Sarah Stoddard

Resources

• Brooklyn, J.R., & Sigmon, S.C. (2017). Vermont Hub-and-Spoke Model of Care for Opioid Use Disorder: Development, Implementation, and Impact. J Addict Med, 11(4), 286-292.doi:10.1097/ADM.0000000000000310
• Keyes, K.M., Cerda, M., Brady, J.E., Havens, J.R., & Galea, S. (2014). Understanding the Rural-Urban Differences in Nonmedical Prescription Opioid Use and Abuse in the United States. Am J Public Health, 104(2), e52-e59. doi:10.2105/AJPH.2013.301709
• Kolodny, A., Courtwright, D.T., Hwang, C.S., Kreiner, P., Eadie, J.L., Clark, T.W., & Alexander, G.C. (2015). The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction. Annual Review of Public Health, 36, 559-574.
• OPEN: Opioid Prescribing Engagement Network. (2022, October). https://michigan-open.org/
• Video, Telephone, In-Person Buprenorphine Treatment for OUD During Pandemic, JAMA Network Open, doi:10.1001/jamanetworkopen.2022.36298

Accessibility Statement: The University of Michigan Medical School is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Activity Coordinator.

Mitigation of Relevant Financial Relationships

The University of Michigan Medical School adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, or others are required to disclose all relevant financial relationships with ineligible entities. 

All of the relevant financial relationships listed for those individuals have been mitigated.

• Daniel Clauw, MD, a presenter of educational event, had a Consultant/Advisory Role for Swing Therapeutics.

No other planners or presenters  for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.